Picture of Renerve logo

RNV — Renerve Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Renerve, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
AAS
AAS
AAS
AAS
AAS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-1.86-1.470.3860.6310.624
Other Operating Cash Flow
Cash from Operating Activities-1.86-1.47-2.29-2.98-5.8
Capital Expenditures-0.116-0.043-0.005-0.048-0.074
Purchase of Fixed Assets
Other Investing Cash Flow Items0-0.5140.512-0.017-0.074
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities-0.116-0.5570.507-0.065-0.147
Financing Cash Flow Items———-0.654-0.278
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.5220.8197.092.76
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.459-0.031-0.9684.04-3.27